LAVA Medtech Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVAC research report →
Price Chart
About the company
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations.
- CEO
- Anthony Natale
- IPO
- 2021
- HQ
- Waltham, MA, US
Get TickerSpark's AI analysis on LVAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $149.93M
- P/E
- 33.65
- PEG
- -0.57
- P/S
- 0.00
- P/B
- 1.29
- EV/EBITDA
- -95.31
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 3.96%
- ROIC
- -1.26%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,561,000
- Net Income
- $4.50M-74.9%
- EPS
- $0.31-75.2%
- OCF Growth
- +35.9%
- FCF Growth
- +35.9%
- 52W High
- $10.85
- 52W Low
- $9.94
- 50D MA
- $10.42
- 200D MA
- $10.23
- Beta
- 0.00
- RSI (14)
- 61
- Avg Volume
- 44.33K
No earnings-call transcripts are available for LVAC yet.
- Free Float
- 60.6%
- Shares Outstanding
- 14.37M
- Float Shares
- 8.71M
of shares held by institutions
55 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 21 | Larcina Vasco | other | 0 |
| Oct 26, 21 | LAVA Medtech Sponsor LP | other | 2,875,000 |
| Oct 26, 21 | EMMITT RICHARD B | other | 0 |
| Oct 26, 21 | van der Velden Peter | other | 0 |
| Oct 26, 21 | BRUNK GERALD A | other | 0 |
| Oct 26, 21 | LaPorte Fritz L | other | 0 |
| Oct 26, 21 | Hetu Daniel | other | 0 |
| Oct 26, 21 | Natale Anthony | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LVAC coverage
Recent articles, reports, and earnings notes.
No research on LVAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LVAC report →